NCT01411254View on ClinicalTrials.gov

Efficacy and Safety of Betamethasone Microsphere in Patients With Diabetic Macular Edema (TSUBASA)

PHASE2/PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Diabetic Macular Edema
Interventions
DRUG

Betamethasone Microsphere (DE-102） Low Dose

DRUG

Betamethasone Microsphere (DE-102） High Dose

DRUG

Sham

Trial Locations (1)

Unknown

Santen study sites, Osaka

All Listed Sponsors
lead

Santen Pharmaceutical Co., Ltd.

INDUSTRY

NCT01411254 - Efficacy and Safety of Betamethasone Microsphere in Patients With Diabetic Macular Edema (TSUBASA) | Biotech Hunter | Biotech Hunter